Profil
Alejandro Sanchez co-founded Evidity Health Capital with Paul Enever in 2014.
He has nearly a decade of experience in PE/VC investing and has been advising boards and C-suite executives in the technology sector on commercialization, operations, and strategy for nearly 20 years.
Prior to joining Evidity, Alejandro was a co-founder and partner of Hermes Growth Partners, where he launched its Telecom, Media, and Technology Fund.
He is a former partner at McKinsey and Company, where he worked in the telecom, media, and technology sectors across a diverse set of geographies, including the United States, Russia, Poland, Chile, Brazil, and Venezuela.
He serves on the Boards of Directors of Endogastric Solutions, Poseidon Medical and PreludeDx, and he is a board observer at Akili Interactive Labs.
Alejandro is a systems engineer with an MS in Engineering-Economic Systems from Stanford University.
Aktive Positionen von Alejandro Sanchez
| Unternehmen | Position | Beginn |
|---|---|---|
Evidity Capital LLC
Evidity Capital LLC Investment ManagersFinance Evidity Capital invests in companies located in the United States with an investment size upto USD 5 million. The firm focuses on companies operating in the fields of medical devices, diagnostics and digital health sector. It provides financing for late and growth stage transactions | Gründer | 01.01.2014 |
Prelude Corp.
Prelude Corp. BiotechnologyHealth Technology Develops breast cancer tools to manage early stage breast cancer | Direktor/Vorstandsmitglied | 22.03.2022 |
Ehemalige bekannte Positionen von Alejandro Sanchez
| Unternehmen | Position | Ende |
|---|---|---|
Hermes Growth Partners Ltd.
Hermes Growth Partners Ltd. Investment ManagersFinance Hermes Growth Partners invests in b2b technology, enterprise software, infrastructure, internet of things, data analytics, AI, robotics technologies and machine learning companies across the world. They provide financing for growth capital requirements. | Private Equity Investor | 31.12.2013 |
McKinsey & Co., Inc.
McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a management consulting firm | Private Equity Investor | 30.09.2011 |
Tafkak, Inc.
Tafkak, Inc. Miscellaneous Commercial ServicesCommercial Services Provides genome sequencing and analysis solutions | Direktor/Vorstandsmitglied | - |
Ausbildung von Alejandro Sanchez
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 7 |
|---|---|
Tafkak, Inc.
Tafkak, Inc. Miscellaneous Commercial ServicesCommercial Services Provides genome sequencing and analysis solutions | Commercial Services |
McKinsey & Co., Inc.
McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a management consulting firm | Commercial Services |
Stanford University
Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Universidad Metropolitana
Universidad Metropolitana Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Hermes Growth Partners Ltd.
Hermes Growth Partners Ltd. Investment ManagersFinance Hermes Growth Partners invests in b2b technology, enterprise software, infrastructure, internet of things, data analytics, AI, robotics technologies and machine learning companies across the world. They provide financing for growth capital requirements. | Finance |
Prelude Corp.
Prelude Corp. BiotechnologyHealth Technology Develops breast cancer tools to manage early stage breast cancer | Health Technology |
Evidity Capital LLC
Evidity Capital LLC Investment ManagersFinance Evidity Capital invests in companies located in the United States with an investment size upto USD 5 million. The firm focuses on companies operating in the fields of medical devices, diagnostics and digital health sector. It provides financing for late and growth stage transactions | Finance |
















